• Markets
    • icon
  • Companies
ADR · ASX

Adherium Ltd. (ASX:ADR)

AU$0.012

 -0.001 (-7.692%)
ASX:Live
06/09/2024 11:46:01 AM
HALO Ords GROWTH AUS Consensus Expensive All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ADR Overview

ADR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About ADR

Website

Adherium Ltd.

Telephone

N/A

Address

Level 14 333 Collins Street Melbourne, Victoria (VIC) 3000

Description

Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. It operates through the following geographical segments: New Zealand and Australia, South-East Asian Countries, and Other Countries. The firm's Hailie system is transforming management of chronic respiratory conditions, especially asthma and chronic obstructive pulmonary disease. The company was founded by Garth Sutherland in 2001 and is headquartered in Melbourne, Australia.

ADR Price Chart

Key Stats

Market Cap

AU$11.38M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.09

Trade Value (12mth)

US$4,593.00

1 week

-13.33%

1 month

-18.75%

YTD

-76.52%

1 year

-81.84%

All time high

10.31

Key Fundamentals

EPS 3 yr Growth

57.50%

EBITDA Margin

%

Operating Cashflow

-$11m

Free Cash Flow Return

-134.80%

ROIC

-129.90%

Interest Coverage

-5,732.20

Quick Ratio

2.40

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.00

ADR Announcements

Latest Announcements

Date Announcements

30 August 24

Update - Notification of cessation of securities - ADR

×

Update - Notification of cessation of securities - ADR

29 August 24

Preliminary Final Report

×

Preliminary Final Report

30 July 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

25 July 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

10 July 24

Notification of cessation of securities - ADR

×

Notification of cessation of securities - ADR

03 July 24

Change of Director's Interest Notice - L Panaccio

×

Change of Director's Interest Notice - L Panaccio

03 July 24

Change of Director's Interest Notice - G Baran

×

Change of Director's Interest Notice - G Baran

02 July 24

Becoming a substantial holder

×

Becoming a substantial holder

01 July 24

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

01 July 24

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

01 July 24

Application for quotation of securities - ADR

×

Application for quotation of securities - ADR

21 June 24

Results of Extraordinary General Meeting

×

Results of Extraordinary General Meeting

18 June 24

Adherium secures a strategic partnership with VRI

×

Adherium secures a strategic partnership with VRI

05 June 24

Change in substantial holding - Updated

×

Change in substantial holding - Updated

04 June 24

Change in substantial holding

×

Change in substantial holding

03 June 24

Change of Director's Interest Notice - B McHarrie

×

Change of Director's Interest Notice - B McHarrie

03 June 24

Change of Director's Interest Notice - G Baran

×

Change of Director's Interest Notice - G Baran

03 June 24

Change of Director's Interest Notice - L Panaccio

×

Change of Director's Interest Notice - L Panaccio

30 May 24

Change in substantial holding

×

Change in substantial holding

29 May 24

Change in substantial holding

×

Change in substantial holding

29 May 24

Change in substantial holding

×

Change in substantial holding

28 May 24

Becoming a substantial holder

×

Becoming a substantial holder

27 May 24

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

27 May 24

Application for quotation of securities - ADR

×

Application for quotation of securities - ADR

24 May 24

AstraZeneca selected Adherium Smartinhaler for its study

×

AstraZeneca selected Adherium Smartinhaler for its study

ADR Fundamentals

Per Share Records

Historical data

Forecast data

NZD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.07 -0.03 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.07 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 72.3 47.8 23.8 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.05 -0.03 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.07 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.1 51.4 44.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -65.0 -91.3 -151.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.04 0.03 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.04 0.03 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -62.0 -26.5 -66.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 152 285 389 Lock Lock Lock
Basic m Lock Lock Lock Lock 152 285 389 Lock Lock Lock

Financial Records

Historical data

Forecast data

NZD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 1 3 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.9 504.0 -73.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 14 11 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 2 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.5 345.2 -137.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -130.4 53.0 -76.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 230 47 176 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -13 -12 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.6 7.4 -1.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,392.2 -366.9 -1,412.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -13 -12 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.8 7.2 -0.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,427.4 -372.8 -1,425.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -13 -12 -12 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -2 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -10 -10 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 33.2 1.9 -3.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1,898.7 -308.5 -1,215.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -10 -9 -11 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 13 8 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -10 -9 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.5 5.8 -13.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -18.7 -2.9 -12.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 5 9 6 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 9 13 10 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 -9 -6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 3 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 6 9 6 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 6 9 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -60.2 65.1 -29.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -117.7 -77.7 -103.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -181.4 -107.0 -157.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -130.7 -160.1 -151.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -102.4 -133.3 -129.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -98.0 -125.4 -134.8 Lock Lock Lock

Ratios Records

Historical data

Forecast data

NZD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -12,655.0 -1,953.5 -5,732.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.4 0.8 0.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.9 -98.0 -94.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.8 3.6 2.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 2.4 3.3 2.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 64.3 72.5 63.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -325.4 -267.6 -315.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.5 1.8 0.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.2 1.3 1.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.4 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 63.3 30.0 326.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.3 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.3 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -2,429.3 -366.1 -1,388.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -150.6 -92.2 -118.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -117.7 -77.7 -103.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 1.4 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -181.4 -107.0 -157.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -181.4 -107.0 -157.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 304.4 280.5 347.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 738.3 203.4 817.1 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 1,042.6 483.9 1,164.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 142.4 141.2 370.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 900.3 342.7 794.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ADR Shortsell

Frequently Asked Questions

The current share price of Adherium Ltd. (ADR:ASX) is AU$0.012.
The 52-week high share price for Adherium Ltd. (ADR:ASX) is AU$0.09.
The 52-week low share price for Adherium Ltd. (ADR:ASX)? is AU$0.01.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) has a franking level of 0.0%.
Adherium Ltd. (ADR:ASX) is classified in the Healthcare.
The current P/E ratio for Adherium Ltd. (ADR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.